Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglin Kang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Medicine|September 5, 2025
Ferroptosis and head and neck cancer: Mechanisms and therapeutic perspectives (Review)Chenglin Kang, Xiaomei Li, Xudong Wei
Experimental and Therapeutic Medicine|July 2, 2026
Role and mechanism of quercetin via the TLR4/MyD88/IRAK4 signaling pathway in the treatment of allergic rhinitisChenglin Kang, Jiangqi Liu, Shuqi Qiu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 3, 2025
Voltage-gated potassium channels associated with head and neck cancerChenglin Kang, Xiaomei Li, Xiaolong Yang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|May 25, 2024
[Progress in dendritic cell-derived exosomes in allergic rhinitis]Chenglin Kang, Peng Liu, Yue Liu, et al.
Journal of Asthma and Allergy|October 14, 2022
Research Advances in the Treatment of Allergic Rhinitis by ProbioticsPeng Liu, Tianyong Hu, Chenglin Kang, et al.
RSC Advances|June 18, 2024
Liquid-phase xylene isomerization on nano-sized ZSM-5Peixi Feng, Chenglin Kang, Xin Yue, et al.
RSC Advances|June 14, 2024
Conversion of C<sub>8</sub> aromatics over a dual-bed catalystPeixi Feng, Chenglin Kang, Zhenhuan Zhou, et al.
Discover Oncology|September 14, 2023
Identification of galactosamine-(N-acetyl)-6-sulfatase (GALNS) as a novel therapeutic target in progression of nasopharyngeal carcinomaJin Zhang, Hong Ran, Zhen Wang, et al.
International Immunopharmacology|November 20, 2022
The role of dendritic cells in allergic diseasesPeng Liu, Chenglin Kang, Jin Zhang, et al.
Discover Oncology|June 23, 2023
TOM40 regulates the progression of nasopharyngeal carcinoma through ROS-mediated AKT/mTOR and p53 signalingHong Ran, Jin Zhang, Xiaoxia Zeng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Medicine|September 5, 2025
Ferroptosis and head and neck cancer: Mechanisms and therapeutic perspectives (Review)Chenglin Kang, Xiaomei Li, Xudong Wei
Experimental and Therapeutic Medicine|July 2, 2026
Role and mechanism of quercetin via the TLR4/MyD88/IRAK4 signaling pathway in the treatment of allergic rhinitisChenglin Kang, Jiangqi Liu, Shuqi Qiu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 3, 2025
Voltage-gated potassium channels associated with head and neck cancerChenglin Kang, Xiaomei Li, Xiaolong Yang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|May 25, 2024
[Progress in dendritic cell-derived exosomes in allergic rhinitis]Chenglin Kang, Peng Liu, Yue Liu, et al.
Journal of Asthma and Allergy|October 14, 2022
Research Advances in the Treatment of Allergic Rhinitis by ProbioticsPeng Liu, Tianyong Hu, Chenglin Kang, et al.
RSC Advances|June 18, 2024
Liquid-phase xylene isomerization on nano-sized ZSM-5Peixi Feng, Chenglin Kang, Xin Yue, et al.
RSC Advances|June 14, 2024
Conversion of C<sub>8</sub> aromatics over a dual-bed catalystPeixi Feng, Chenglin Kang, Zhenhuan Zhou, et al.
Discover Oncology|September 14, 2023
Identification of galactosamine-(N-acetyl)-6-sulfatase (GALNS) as a novel therapeutic target in progression of nasopharyngeal carcinomaJin Zhang, Hong Ran, Zhen Wang, et al.
International Immunopharmacology|November 20, 2022
The role of dendritic cells in allergic diseasesPeng Liu, Chenglin Kang, Jin Zhang, et al.
Discover Oncology|June 23, 2023
TOM40 regulates the progression of nasopharyngeal carcinoma through ROS-mediated AKT/mTOR and p53 signalingHong Ran, Jin Zhang, Xiaoxia Zeng, et al.
Pageof 2